CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013
5/22/2013 9:36:52 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that Daniel Teper, Chief Executive Officer of Immune, will be presenting
at the BioEquity Europe 2013 conference at the Varumottagning Sheraton Hotel in
Stockholm, Sweden on Thursday, May 23, at 1:30 PM local time in the St.
Eriksalen Room. Dr. Teper will provide an update on the Immune/EpiCept merger
and present an overview of the companies' products bertilimumab, NanomAbs, and
AmiKet. The presentation will not be webcast, but the slide presentation will be
available on both companies' websites."
Help employers find you! Check out all the jobs and post your resume.